Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy
Percutaneous revascularisation has evolved dramatically in the past few decades. The approach to the management of ischaemic heart disease has changed due to the development of new devices and techniques as well as the availability of new drugs and treatment strategies. Its use in combination with a...
Saved in:
| Main Authors: | Tamara García Camarero, José M de la Torre Hernández |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-02-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2019.25.2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021-06-01) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
by: Despoina-Rafailia Benetou, et al.
Published: (2021-05-01) -
Individualising Antithrombotic Strategies for Acute and Chronic Coronary Syndromes
by: Robert F Storey
Published: (2024-05-01) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021-05-01) -
Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment
by: N. S. Lapina, et al.
Published: (2020-07-01)